News vTv's azeliragon is latest Alzheimer's drug failure vTv to stop all studies after STEADFAST trial failure
News BI strikes billion-dollar cancer immunotherapy deal with OSE Could BI be looking to develop combination therapy?
News Pfizer's lung cancer drug dacomitinib gets fast US review Drug beat AZ's Iressa in head-to-head trial, concerns over side-effects
News Novo cleared to add key data to Tresiba label Novo Nordisk can add data showing Tresiba can reduce the risk of hypoglycaemia to its label, a development which should help its fight competition from cheaper alternati
News Concerns mount over Biogen Alzheimer's drug FDA announces guidance to encourage development of new drugs
News Boehringer latest to axe Alzheimer's drug Company will trial BI 409306 in schizophrenia instead.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.